5'-N-Ethylcarboxamidoadenosine (NECA), 5mg

5'-N-Ethylcarboxamidoadenosine (NECA, 5'-(N-Ethylcarboxamido)adenosine, Adenosine-5'N-ethylcarboxamide, 5'-Ethylcarboxamidoadenosine) is a stable, nonselective adenosine receptoragonist. 5'-N-Ethylcarboxamidoadenosine acts via multiple mechanisms including: reducing diabetes-induced oxidative stress, inhibiting gene expression of IL-18, TNF-αand ICAM-1 (intercellular adhesion molecule 1 (CD54)), and blocking activation of the JNK-MAPKpathway.